vimarsana.com
Home
Live Updates
KarXT Effective in Improving Schizophrenia Symptoms at 52 Weeks : vimarsana.com
KarXT Effective in Improving Schizophrenia Symptoms at 52 Weeks
EMERGENT-3 trial showed xanomeline-trospium was effective in improving schizophrenia symptoms at 52 weeks, for participants who took either placebo or KarXT in acute trials.
Related Keywords
Italy ,
Bristol Myers Squibb ,
Roland Chen ,
C Andrew Miller ,
Cenexel Hassman Research Institute Elan Cohen ,
Schizophrenia International Research Society ,
Cenexel Hassman Research Institute ,
Drug Administration ,
Elan Cohen ,
Myers Squibb ,
Annual Congress ,
Cenexel Hassman Research ,
New Drug Application ,
Rishi Kakar ,
Segal Trials ,
Negative Syndrome Scale ,
Clinical Global Impression Severity ,
Schizophrenia At The ,
Bristol Myers ,
Xanomeline Trospium Drug Application ,
Schizophrenia ,
Karxt ,
Xanomeline Trospium ,
Emergent Trials ,
Emergent 2 ,
Emergent ,
Emergent 3 ,
Emergent 4 ,
Schizophrenia Treatment ,
Schizophrenia In Adults ,
vimarsana.com © 2020. All Rights Reserved.